Frugalis Bioproducts Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -16.87%
- Profit Growth -179.13%
- Ebitda -175.06%
- Net Worth -342.11%
- Total Assets -27.85%
About Frugalis Bioproducts
Frugalis Bioproducts Private Limited (FBPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 28 February 2019 (Five years and 11 months 4 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Johan Aasen, Gaurav Patel, and Anmol Sharma serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2019FTC106865
-
Company No.
106865
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
28 Feb 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Frugalis Bioproducts?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Johan Aasen
|
Director | 28-Feb-2019 | Current |
Gaurav Patel
|
Director | 28-Feb-2019 | Current |
|
Anmol Sharma
|
Director | 28-Feb-2019 | Current |
Financial Performance of Frugalis Bioproducts.
Frugalis Bioproducts Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.87% decrease. The company also saw a substantial fall in profitability, with a 179.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 342.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Frugalis Bioproducts?
In 2023, Frugalis Bioproducts had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Segel India Private LimitedJohan Aasen and Anmol Sharma are mutual person
-
Aidequate India Private LimitedAnmol Sharma is a mutual person
-
Nordic Wellness Private LimitedJohan Aasen, Gaurav Patel and 1 more are mutual person
-
Amore Agro Exim Llp
Gaurav Patel is a mutual person
-
Allbys Agro & Seeds Industries Private Limited
Gaurav Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Frugalis Bioproducts?
Unlock and access historical data on people associated with Frugalis Bioproducts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Frugalis Bioproducts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Frugalis Bioproducts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.